Evidence map›Paper›PMID 32719457›Full record

ArticleNature structural & molecular biology2020

Structural basis of CD4 downregulation by HIV-1 Nef.

Yonghwa Kwon, Robyn M Kaake, Ignacia Echeverria, Marissa Suarez, Mohammad Karimian Shamsabadi, Charlotte Stoneham, Peter W Ramirez, Jacob Kress, Rajendra Singh, Andrej Sali and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Host Subcellular Organelles: Targets of Viral Manipulation.International journal of molecular sciences · 2024
    Review
  13. Article
  14. HIV-1 subtypes maintain distinctive physicochemical signatures in Nef domains associated with immunoregulation.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Impact ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Yonghwa KwonDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, Dartmouth, MA, USA.
Robyn M KaakeDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
Ignacia EcheverriaDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Marissa SuarezThe VA San Diego Healthcare System, San Diego, CA, USA.
Mohammad Karimian ShamsabadiDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, Dartmouth, MA, USA.ORCID http://orcid.org/0000-0003-3392-9951
Charlotte StonehamThe VA San Diego Healthcare System, San Diego, CA, USA.
Peter W RamirezDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Jacob KressDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, Dartmouth, MA, USA.
Rajendra SinghThe VA San Diego Healthcare System, San Diego, CA, USA.
Andrej SaliDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Nevan KroganDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-4902-337X
John GuatelliThe VA San Diego Healthcare System, San Diego, CA, USA.
Xiaofei JiaDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, Dartmouth, MA, USA. xjia@umassd.edu.ORCID http://orcid.org/0000-0002-0972-3884
University of California San Diego · USUniversity of Massachusetts Dartmouth · USGladstone Institutes · USUniversity of California, San Francisco · USVA San Diego Healthcare System · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2007 to 2018
$48.8M
RESEARCH PROJECT 2U19AI135990 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Melanie Maria Ott · 2018 to 2026
$21.4M
TR&D Project 4. The Imaging Stage: Multiscale Spatiotemporal Modeling of Macromolecular Systems in Cellular NeighborhoodsP41GM109824 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2014 to 2023
$18.8M
X-ray Screening and Rapid Structure DeterminationP50AI150476 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2019 to 2021
$14.4M
IMP: Software for Hybrid Determination of Macromolecular Assembly StructuresR01GM083960 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 2008 to 2024
$5.2M
Viral Hijacking of Host Membrane Trafficking PathwaysR01AI102778 · NIAID · YALE UNIVERSITY · PI GUATELLI, JOHN C., XIONG, YONG · 2013 to 2017
$3.0M
Enhancement of Infectivity by HIV-1 Nef via Antagonism of SERINC ProteinsR01AI129706 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUATELLI, JOHN C. · 2017 to 2021
$2.8M
High Performance Computer for Computational BiosciencesS10OD021596 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 2016 to 2016
$443k
Reactivation of Innate Immune Response Pathways as Treatment for HIV InfectionF32AI127291 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI KAAKE, ROBYN MIDORI · 2016 to 2018
$178k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS F32 AI127291NIAID NIH HHS P30 AI036214NIAID NIH HHS P50 AI150476NIAID NIH HHS R01 AI102778NIAID NIH HHS R01 AI129706NIAID NIH HHS U19 AI135990NIGMS NIH HHS P41 GM109824NIGMS NIH HHS P50 GM082250NIGMS NIH HHS R01 GM083960NIH HHS S10 OD021596
6 · The paper itself

Abstract

The HIV-1 Nef protein suppresses multiple immune surveillance mechanisms to promote viral pathogenesis and is an attractive target for the development of novel therapeutics. A key function of Nef is to remove the CD4 receptor from the cell surface by hijacking clathrin- and adaptor protein complex 2 (AP2)-dependent endocytosis. However, exactly how Nef does this has been elusive. Here, we describe the underlying mechanism as revealed by a 3.0-Å crystal structure of a fusion protein comprising Nef and the cytoplasmic domain of CD4 bound to the tetrameric AP2 complex. An intricate combination of conformational changes occurs in both Nef and AP2 to enable CD4 binding and downregulation. A pocket on Nef previously identified as crucial for recruiting class I MHC is also responsible for recruiting CD4, revealing a potential approach to inhibit two of Nef's activities and sensitize the virus to immune clearance.

Indexed as

Adaptor Protein Complex 2CD4 AntigensCrystallography, X-RayHeLa CellsHIV-1HIV InfectionsHost-Pathogen InteractionsHumansModels, Molecularnef Gene Products, Human Immunodeficiency VirusProtein BindingProtein ConformationProtein DomainsAdaptor Protein Complex 2CD4 Antigensnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1

Identifiers

PMID32719457
PMCPMC7483821
OpenAlexW3044020843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.